GraniteShares 2x Long ISRG Daily ETF (ISUL) seeks to provide 200% of the daily performance of Intuitive Surgical Inc. (ISRG) stock. This single-stock leveraged ETF amplifies exposure to the leading robotic surgery company that develops the da Vinci surgical system used in minimally invasive procedures worldwide.
How It Works
ISUL uses derivatives including swaps and futures contracts to deliver twice the daily return of ISRG stock through mathematical leverage rather than borrowing. The fund resets daily at market close, meaning each day's 2x exposure is independent of previous days. Holdings consist primarily of cash collateral and derivative instruments rather than actual ISRG shares. Daily rebalancing ensures consistent 2x leverage but creates compounding effects over multi-day periods.
Key Features
- Provides 2x leveraged exposure to Intuitive Surgical, the dominant robotic surgery platform with 80%+ global market share
- Daily reset mechanism maintains precise 2x leverage each trading day regardless of underlying stock volatility
- Newly launched ETF offering focused exposure to surgical robotics innovation and minimally invasive procedure adoption trends
Risks
- This ETF can lose value rapidly due to daily compounding effects—if ISRG drops 10% then rises 10%, the fund does NOT return to break-even
- Single-stock concentration means 100% exposure to Intuitive Surgical's business risks including regulatory changes, competition, and healthcare spending cuts that could cause 50%+ declines
- Leveraged structure amplifies all volatility, potentially causing 40-60% daily swings during earnings announcements or major medical device news affecting ISRG
Who Should Own This
Suitable only for active traders with high risk tolerance and intraday to weekly time horizons seeking amplified exposure to robotic surgery trends. Requires constant monitoring and should represent less than 5% of total portfolio. Not appropriate for buy-and-hold investors due to daily reset compounding effects that erode returns over extended periods.